Coexistence of Hereditary Spastic Paraplegia Type 4 and Narcolepsy: A Case Report

被引:1
作者
Nagai, Takahiro [1 ,2 ]
Sunami, Yoko [3 ]
Kato, Risa
Sugai, Megumi [4 ]
Takahara, Makoto [5 ]
Ohta, Kentaro [1 ]
Fujinaka, Hidehiko [6 ,7 ]
Goto, Kiyoe [8 ]
Okanura, Osamu [4 ]
Nakajima, Takashi [1 ]
Ozawa, Tetsuo [5 ]
机构
[1] Natl Hosp Org Niigata Natl Hosp, Dept Neurol, Kashiwazaki, Japan
[2] Niigata Univ, Brain Res Inst, Dept Neurol, Niigata, Japan
[3] Tokyo Metropolitan Neurol Hosp, Dept Neurol, Fuchu, Tokyo, Japan
[4] Natl Hosp Org Niigata Natl Hosp, Dept Clin Lab, Kashiwazaki, Japan
[5] Natl Hosp Org Niigata Natl Hosp, Dept Internal Med, 3-52 Akasaka Cho, Kashiwazaki 9458585, Japan
[6] Natl Hosp Org Niigata Natl Hosp, Dept Pediat, Kashiwazaki, Japan
[7] Natl Hosp Org Niigata Natl Hosp, Dept Clin Res, Kashiwazaki, Japan
[8] Natl Hosp Org Niigata Natl Hosp, Dept Genet Counseling, Kashiwazaki, Japan
关键词
Spastic paraplegia; Spastic paraplegia type 4; Spastin; Narcolepsy; Hypocretin; EPIDEMIOLOGY; PEPTIDES; PROTEIN;
D O I
10.1159/000512404
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Spastic paraplegia type 4 (SPG4) is the most common type of hereditary spastic paraplegia (HSP) caused by the mutations in the SPAST gene, which encodes a microtubule-severing protein named spastin. Spastin regulates the number and mobility of microtubules and is essential for axonal outgrowth and neuronal morphogenesis. Herein, we report a patient with SPG4 harboring a novel donor splice site mutation in the SPAST gene (c.1616+1dupG). Although SPG4 usually manifests itself as a pure form of HSP, this patient exhibited a slow progressive cognitive decline and also developed narcolepsy type 2 (narcolepsy without cataplexy) prior to the onset of SPG4. Recently, cognitive decline has attracted attention as a main non-motor symptom of SPG4. However, this is the first reported case of a patient developing both SPG4 and narcolepsy, although it remains unclear whether the manifestation of the two diseases is a coincidence or an association. In this report, we describe the clinical symptoms and genetic background of the patient.
引用
收藏
页码:84 / 91
页数:8
相关论文
共 15 条
  • [11] The Global Epidemiology of Hereditary Ataxia and Spastic Paraplegia: A Systematic Review of Prevalence Studies
    Ruano, Luis
    Melo, Claudia
    Carolina Silva, M.
    Coutinho, Paula
    [J]. NEUROEPIDEMIOLOGY, 2014, 42 (03) : 174 - 183
  • [12] Sakurai T., 2015, OREXIN SLEEP, DOI [10.1007/978-3-319-23078-8, DOI 10.1007/978-3-319-23078-8]
  • [13] Evaluation of loss of function as an explanation for SPG4-based hereditary spastic paraplegia
    Solowska, Joanna M.
    Garbern, James Y.
    Baas, Peter W.
    [J]. HUMAN MOLECULAR GENETICS, 2010, 19 (14) : 2767 - 2779
  • [14] Hypocretin (orexin) cell loss in Parkinson's disease
    Thannickal, Thomas C.
    Lai, Yuan-Yang
    Siegel, Jerome M.
    [J]. BRAIN, 2007, 130 : 1586 - 1595
  • [15] The microtubule-severing protein Spastin is essential for axon outgrowth in the zebrafish embryo
    Wood, Jonathan D.
    Landers, Jennifer A.
    Bingley, Megan
    McDermott, Christopher J.
    Thomas-McArthur, Vickie
    Gleadall, Lisa J.
    Shaw, Pamela J.
    Cunliffe, Vincent T.
    [J]. HUMAN MOLECULAR GENETICS, 2006, 15 (18) : 2763 - 2771